Your Health

Why Cardinal Health Decided to Buy J&J’s Cordis Unit

March 2 -- Cardinal Health Inc. agreed to buy Johnson & Johnson’s Cordis business for $1.94 billion in cash, bulking up the medical distributor’s device-making capabilities. Cardinal Health CEO George Barret discusses the acquisition on “Bloomberg West.”